Inventiva (IVEVF) Cash from Investing Activities (2019 - 2025)
Inventiva (IVEVF) posted Cash from Investing Activities of -$28.1 million for Q2 2025, down 10166.56% on a QoQ basis from -$273426.3 in Q4 2022.
Analysis
Inventiva (IVEVF) Cash from Investing Activities (2019 - 2025) Analysis & Trends
Inventiva has reported Cash from Investing Activities for 5 years, with the latest figure at -$28.1 million in Q2 2025.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$28.1 million in Q2 2025; TTM through Jun 2025 was -$23.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$155.0 million, down 1759.03% from the prior year.
- Cash from Investing Activities was -$28.1 million for Q2 2025 at Inventiva, down from -$273426.3 in the prior quarter.
- The five-year high for Cash from Investing Activities was $7.7 million in Q1 2021, with the low at -$28.1 million in Q2 2025.
- Average Cash from Investing Activities over 3 years is -$2.9 million, with a median of -$276534.1 recorded in 2022.
- The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities jumped 553.88% in 2021, then slumped 105.04% in 2022.
- Over 3 years, Cash from Investing Activities stood at $5.4 million in 2021, then plunged by 105.04% to -$273426.3 in 2022, then tumbled by 10166.56% to -$28.1 million in 2025.
- The last three Cash from Investing Activities figures came in at -$28.1 million (Q2 2025), -$273426.3 (Q4 2022), and -$279641.8 (Q3 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | -1.11 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | -1.20 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | -5.60 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | -3.11 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 2.11 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -424.26 Mn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -1.66 Bn |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | -51.79 Mn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | 87.50 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -28.07 Mn |
| Dec 31, 2022 | -273,426.29 |
| Sep 22, 2022 | -279,641.81 |
| Dec 31, 2021 | 5.42 Mn |
| Jun 30, 2021 | -1.97 Mn |
| Mar 31, 2021 | 7.69 Mn |
| Dec 31, 2020 | -1.19 Mn |
| Dec 31, 2019 | -928,678.76 |